title: PSA screening in men newly diagnosed with colorectal cancer: each according to his group's means?
authors.affiliation: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Davis
authors.affiliation: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Pisansky
authors.affiliation: Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
authors.forename: William J
authors.initials: WJ
authors.lastname: Catalona
mesh_terms: D015179:Colorectal Neoplasms / Q000401:mortality*; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*
chemical_list: D017430:Prostate-Specific Antigen